Niagen Bioscience (NAGE) Current Assets: 2011-2025
Historic Current Assets for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $93.6 million.
- Niagen Bioscience's Current Assets rose 79.57% to $93.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.6 million, marking a year-over-year increase of 79.57%. This contributed to the annual value of $64.1 million for FY2024, which is 29.41% up from last year.
- Latest data reveals that Niagen Bioscience reported Current Assets of $93.6 million as of Q3 2025, which was up 8.00% from $86.7 million recorded in Q2 2025.
- In the past 5 years, Niagen Bioscience's Current Assets ranged from a high of $93.6 million in Q3 2025 and a low of $37.9 million during Q3 2022.
- For the 3-year period, Niagen Bioscience's Current Assets averaged around $60.1 million, with its median value being $49.5 million (2023).
- Its Current Assets has fluctuated over the past 5 years, first tumbled by 33.53% in 2022, then skyrocketed by 79.57% in 2025.
- Quarterly analysis of 5 years shows Niagen Bioscience's Current Assets stood at $48.9 million in 2021, then decreased by 4.78% to $46.6 million in 2022, then grew by 6.37% to $49.5 million in 2023, then climbed by 29.41% to $64.1 million in 2024, then surged by 79.57% to $93.6 million in 2025.
- Its last three reported values are $93.6 million in Q3 2025, $86.7 million for Q2 2025, and $76.2 million during Q1 2025.